Literature DB >> 7664118

The not-so-great escape.

J W Erickson.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7664118     DOI： 10.1038/nsb0795-523

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN： 1072-8368


× No keyword cloud information.
  16 in total

1.  JE-2147: a dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1.

Authors:  K Yoshimura; R Kato; K Yusa; M F Kavlick; V Maroun; A Nguyen; T Mimoto; T Ueno; M Shintani; J Falloon; H Masur; H Hayashi; J Erickson; H Mitsuya
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

2.  A mimic of HIV-1 nucleocapsid protein impairs reverse transcription and displays antiviral activity.

Authors:  S Druillennec; C Z Dong; S Escaich; N Gresh; A Bousseau; B P Roques; M C Fournié-Zaluski
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

3.  Computational study of protein specificity: the molecular basis of HIV-1 protease drug resistance.

Authors:  W Wang; P A Kollman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

4.  Evaluating the substrate-envelope hypothesis: structural analysis of novel HIV-1 protease inhibitors designed to be robust against drug resistance.

Authors:  Madhavi N L Nalam; Akbar Ali; Michael D Altman; G S Kiran Kumar Reddy; Sripriya Chellappan; Visvaldas Kairys; Aysegül Ozen; Hong Cao; Michael K Gilson; Bruce Tidor; Tariq M Rana; Celia A Schiffer
Journal:  J Virol       Date:  2010-03-17       Impact factor: 5.103

Review 5.  Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesis.

Authors:  K Ikuta; S Suzuki; H Horikoshi; T Mukai; R B Luftig
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

6.  Elucidating the Interdependence of Drug Resistance from Combinations of Mutations.

Authors:  Debra A Ragland; Troy W Whitfield; Sook-Kyung Lee; Ronald Swanstrom; Konstantin B Zeldovich; Nese Kurt-Yilmaz; Celia A Schiffer
Journal:  J Chem Theory Comput       Date:  2017-10-09       Impact factor: 6.006

7.  Retracing the evolutionary pathways of human immunodeficiency virus type 1 resistance to protease inhibitors: virus fitness in the absence and in the presence of drug.

Authors:  F Mammano; V Trouplin; V Zennou; F Clavel
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

8.  A mutation in human immunodeficiency virus type 1 protease at position 88, located outside the active site, confers resistance to the hydroxyethylurea inhibitor SC-55389A.

Authors:  M L Smidt; K E Potts; S P Tucker; L Blystone; T R Stiebel; W C Stallings; J J McDonald; D Pillay; D D Richman; M L Bryant
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

9.  Structure of equine infectious anemia virus proteinase complexed with an inhibitor.

Authors:  A Gustchina; J Kervinen; D J Powell; A Zdanov; J Kay; A Wlodawer
Journal:  Protein Sci       Date:  1996-08       Impact factor: 6.725

10.  Resistance-associated loss of viral fitness in human immunodeficiency virus type 1: phenotypic analysis of protease and gag coevolution in protease inhibitor-treated patients.

Authors:  F Mammano; C Petit; F Clavel
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.